| 荣媛 刘明华 邓朝霞 王娟 尹昌林 李晓萍.乌司他丁治疗不同类型急性胰腺炎的临床疗效[J].,2015,15(14):2696-2699 |
| 乌司他丁治疗不同类型急性胰腺炎的临床疗效 |
| Clinical Efficacy of Ulinastatin in the Treatment of Different Typesof Acute Pancreatitis |
| |
| DOI： |
| 中文关键词: 急性胰腺炎 乌司他丁 水肿型胰腺炎 出血坏死型胰腺炎 临床疗效 |
| 英文关键词: Acute pancreatitis Ulinastatin Acute edematous pancreatitis (AEP) Acute hemorrhagic necrotizing pancreatitis
(AHNP) Clinical efficacy |
| 基金项目:国家自然科学基金项目（30972894） |
|
| 摘要点击次数: 521 |
| 全文下载次数: 0 |
| 中文摘要: |
| 目的：探讨乌司他丁用于治疗不同类型急性胰腺炎的临床疗效和安全性。方法：收集2013 年1 月至2014 年1 月我院收治
的急性胰腺炎患者84 例，随机分为观察组与对照组，每组各42 例，两组患者均给予常规治疗，对照组加用奥曲肽治疗，观察组在
对照组的基础上加用乌司他丁治疗，观察和比较两组患者的临床疗效、治疗前后血清IL-6 和TNF-alpha水平的变化及不良反应的发
生情况。结果：观察组的总有效率为96.72%，显著高于对照组的85.71%；其中，两组急性水肿型胰腺炎的疗效相当(P<0.05)，但观
察组出血坏死型胰腺炎的有效率显著高于对照组(P<0.05)。治疗后，两组血清IL-6 与TNF-lalpha水平均较治疗前显著降低，并且观察
组显著低于对照组(P<0.05)，水肿型胰腺炎患者血清IL-6 及TNF-alpha水平显著低于出血坏死型胰腺炎患者，差异均具有统计学意
义(P<0.05)。两组均未发生肝肾功能损害，未见药物相关性不良反应。结论：乌司他丁用于辅助治疗急性胰腺炎能够明显下调炎症
因子水平，临床疗效显著，对急性水肿型胰腺炎的疗效尤为显著，安全性好，值得推广应用。 |
| 英文摘要: |
| Objective:To investigate the clinical efficacy and safety of ulinastatin in treatment of different types of acute
pancreatitis.Methods:84 cases of patients with acute pancreatitis admitted in our hospital from January 2013 to January 2014 were
selected and randomly divided into the observation group and control group. Both groups received conventional treatment, the control
group received octreotide treatment, observation group received ulinastatin on the basis of the control group, the clinical efficacy, serum
IL-6 and TNF-alpha levels before and after treatment, the occurrence of adverse reactions of two groups were compared.Results:The total
effective rate of observation group was 96.72%, which was significantly higher than that of the control group (85.71%); no significant
difference was found in the efficacy of acute edematous pancreatitis (AEP) betwen the two groups (P<0.05), but the efficiency of acute
hemorrhagic necrotizing pancreatitis (AHNP) in the observation group was significantly higher than that of the control group(P<0.05).
After treatment, the serum IL-6 and TNF-alpha levels of both groups were significantly lower than those before treatment (P<0.05), and the
serumIL-6 and TNF-alpha levels of observation group were significantly lower than those of the control group (P<0.05), the serum IL-6 and
TNF-alpha levels of patients with AEP were significantly lower than those with AHNP (P<0.05). There was no significant difference or
drug-related adverse reactions in the liver and kidney dysfunction between two groups.Conclusion:Ulinastatin could significantly lower
the levels of inflammatory factors in the treatment of AEP and AHNP and had significant clinical effect on the AEP, it should be widely
applied in clinic. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
